Open Date
14 Jul 2025
Close Date
16 Jul 2025
Listing Date
21 Jul 2025
Max Investment
₹1,92,660
Price Range
₹570 - ₹570
Lot Size
26
IPO Size
₹3395Cr
Exchange Symbols
Anthem Biosciences Ltd IPO
₹14,820
/ 26
Cutoff - Lot Size
IPO Dates and Timelines
IPO Size
IPO Reservation
Investor Category
Shares Offered
Allocation Percentage %
Anchor Investor Shares Offered
1,78,25,000
-
QIB Shares Offered
2,97,08,334
50.0%
NII (HNI) Shares Offered
89,12,500
15.0%
Retails Shares Offered
2,07,95,833
35.0%
Total Shares Offered
5,95,61,404
-
Total Shares with Anchor Investor
4,75,33,334
100%
IPO Lot Size
Applications
Lot
Shares
Amount
Retail (Min)
1
26
₹14,820
Retail (Max)
13
338
₹1,92,660
S-HNI (Min)
14
364
₹2,07,480
S-HNI (Max)
67
1742
₹9,92,940
B-HNI (Min)
68
1768
₹10,07,760
IPO Shareholding Pattern
Category
Pre-Issue
Post-issue
Promoter Group
76.87%
74.69%
Public Group
23.13%
25.31%
IPO Financials
Total Assets Total Liabilities
Total Revenue Total Expenditure
EBITDA Profit
Share Capital
IPO Peers
Peer Name
P/E(x)
RoNW%
Syngene Internatio nal Limited
51.54
11.05
Sai Life Sciences Limited
92.18
10.96
Cohance Lifescienc es Limited
97.29
13.61
Divi's Laboratori es Limited
83.22
15.35
IPO Strengths & Risks
Strength
Risks
The Company offers comprehensive one-stop service capabilities across the drug life cycle (drug discovery, development and manufacturing) for both small molecules and biologics and it is the fastest growing Indian CRDMO.
Its innovation-focused approach has enabled it to offer a spectrum of technologically advanced solutions across modalities and manufacturing practices.
Wide specialty ingredients portfolio, well positioned to capitalize on the large market opportunity for niche specialty ingredients such as GLP-1, fermentation-based products,
Fully built-out automated manufacturing infrastructure with a consistent regulatory compliance track record.
Its business depends on the demand for the company CRDMO services, which contributed to 81.65% of its revenue from operations in Fiscal 2025. Any adverse impact on its CRDMO customers' business or the industries in which they operate may have a material adverse effect on the company business.IPO Registrars
Limited
The Company is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization ("CRDMO") with fully integrated operations spanning across drug discovery, development and manufacturing with integrated New Chemical Entity ("NCE") and New Biological Entity ("NBE") capabilities across drug discovery, development, and commercial manufacturing. The Company provides end to end CRDMO services and it serves a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally. Our CRDMO platform comprises 5 main modalities (RNAi, ADC, peptides, lipids and oligonucleotides) and 4 manufacturing capabilities (custom synthesis, flow chemistry, fermentation and biotransformation). The Company derives revenue primarily from its CRDMO services, including developmental and commercial manufacturing, and research and development services. It also generate revenue from the manufacture and sale of specialty ingredients.
Contact Details
IPO Company Name:
Limited
Phone Number:
+91 080 6672 4000
Email ID:
Website:
www.anthembio.com
Address:
Bangalore, Karnataka
IPO Overview
: IPO Dates
The IPO opens for subscription on 14 Jul 2025, and closes on 16 Jul 2025. Investors will likely receive their allotment status updates on 17 Jul 2025. Those who get allotted shares can expect them credited to their Demat accounts by 18 Jul 2025. The shares will be officially listed on the stock exchange on 21 Jul 2025.
: IPO Price Band
The IPO consists of a fresh issue and an offer for sale, with a price band set between ₹570.0 and ₹570.0 per share.Investors can apply within this range. This book-building issue includes a fresh issue worth ₹0.0 crore and an offer for sale valued at ₹ 3395.0 crore. The exact listing price will be revealed on 21 Jul 2025, which is when the shares start trading on the exchange.
: Lot Size and Issue Size
The minimum application lot size is shares, and investors need to apply for at least one lot. The total IPO size is approximately - crore.
How to Apply for IPO Online?
- 1. Log in to Torus Digital: Open the Torus Digital app and enter your login details.
- 2. Find the IPO Section: Navigate to the ‘IPO’ tab in the app.
- 3. Select IPO: Choose it from the list of available IPOs.
- 4. Enter Lot Quantity: Input how many lots you want to apply for.
- 5. Provide UPI ID: Submit your UPI ID for payment.
- 6. Approve Payment: When the payment request comes to your UPI app, approve it by entering your UPI PIN.
How to Check IPO Allotment Status for ?
- 1. Open the Torus Digital app and log in.
- 2. Go to the ‘IPO’ section and select ‘IPO Orders’.
- 3. Choose the IPO application.
- 4. View your allotment status.
You will also get notified of your allotment via push notifications and email from Torus Digital.
FAQ’s
What is the open date of IPO?
- The opening date of IPO is 14 Jul 2025.
What is the close date of IPO?
- The closing date of IPO is 16 Jul 2025.
What is the issue size of IPO?
- The issue size of IPO is Rs Cr.
What is the lot size of IPO?
- The size per lot of IPO is 26.0.
How to apply for IPO?
- To apply for IPO:
- Navigate to the IPO section of mobile app/website
- Click on Current IPO
- Click on IPO
- Enter Lot Quantity
- Enter Valid UPI ID
- Click on apply
- Your application will be processed once the transaction is completed successfully.
What is the allotment date of IPO?
- The Allotment Date of IPO is 17 Jul 2025.
What is the listing date of IPO?
- IPO will get listed on .
Who is the registrar of IPO?
- The registrar of IPO is KFin Techologies Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
